DataTrends Publications Releases 10th Edition of "The Guide to Stem Cell Research Companies"
10th Edition delivers the global corporate information that investors, suppliers, researchers, and competitors need to invest intelligently, stay competitive, find potential strategic partners, and drive successful sales and marketing programs.
Leesburg, VA, June 28, 2009 --(PR.com)-- DataTrends Publications, Inc., publisher of Stem Cell Business News and Stem Cell Research News today announced the publication of the 10th Edition of "The Guide to Stem Cell Research Companies," the global directory of public and private companies pursuing stem cell research and stem cell-based therapeutic product development.
Compiled by the research staff of the DataTrends Equity Research Group and the editors of Stem Cell Business News, this timely, comprehensive directory, available for download in PDF format, includes profiles of 99 companies. Sixty-two of the companies listed are privately held; thirty-seven are publicly traded.
The Guide provides instant access to the public and private companies around the world pursuing stem cell-related research and therapeutic product development. The 10th Edition delivers the global corporate information that investors, suppliers, researchers, and competitors need to invest intelligently, stay competitive, find potential strategic partners, and drive successful sales and marketing programs. The "Guide to Stem Cell Companies" delivers the big picture by uncovering patterns, trends and relationships.
“We published our first Guide in 2002,” said Paul G. Ochs, Executive Editor and Publisher. “That edition profiled 54 companies, many of which no longer exist, for one reason or another. But plenty have sprung up to take their place. This 10th Edition is the definitive compilation, containing accurate contact information, up-to-date lists of senior management, overviews of corporate missions and research activities, details on clinical trials, and active Web links to financial, funding and recent news pages, where available. All links (URL and e-mail) are live. This makes the document very useful and useable as a quick reference tool.”
The 10th Edition of the "Guide to Stem Cell Research Companies" (216 pages, 99 companies) is available for immediate download in PDF only. For more information, or to purchase, visit http://www.stemcellresearchnews.com/2009_Guide.htm.
About DataTrends Publications, Inc., and the DataTrends Equity Research Group
DataTrends Publications, Inc., founded in 1987, is the publisher of Stem Cell Research News (1999), Stem Cell Business News (2002), and Stem Cell Lab World (2007), as well as the semi-annual Guide to Stem Cell Research Companies. DataTrends Equity Research Group, a unit of DataTrends Publications, provides independent research to small, growth-oriented public companies. DERG’s Investor’s Corporate Profile® is a comprehensive, detailed summary of a company’s business and growth strategies, history, financial data, leadership, science & technology, commercial products and products in the pipeline, markets, competition, patent portfolio and other intellectual property, strategic alliances, and risk factors.
Source DataTrends Publications, Inc.
http://www.DataTrendsPublications.com and http://www.StemCellResearchNews.com
###
Compiled by the research staff of the DataTrends Equity Research Group and the editors of Stem Cell Business News, this timely, comprehensive directory, available for download in PDF format, includes profiles of 99 companies. Sixty-two of the companies listed are privately held; thirty-seven are publicly traded.
The Guide provides instant access to the public and private companies around the world pursuing stem cell-related research and therapeutic product development. The 10th Edition delivers the global corporate information that investors, suppliers, researchers, and competitors need to invest intelligently, stay competitive, find potential strategic partners, and drive successful sales and marketing programs. The "Guide to Stem Cell Companies" delivers the big picture by uncovering patterns, trends and relationships.
“We published our first Guide in 2002,” said Paul G. Ochs, Executive Editor and Publisher. “That edition profiled 54 companies, many of which no longer exist, for one reason or another. But plenty have sprung up to take their place. This 10th Edition is the definitive compilation, containing accurate contact information, up-to-date lists of senior management, overviews of corporate missions and research activities, details on clinical trials, and active Web links to financial, funding and recent news pages, where available. All links (URL and e-mail) are live. This makes the document very useful and useable as a quick reference tool.”
The 10th Edition of the "Guide to Stem Cell Research Companies" (216 pages, 99 companies) is available for immediate download in PDF only. For more information, or to purchase, visit http://www.stemcellresearchnews.com/2009_Guide.htm.
About DataTrends Publications, Inc., and the DataTrends Equity Research Group
DataTrends Publications, Inc., founded in 1987, is the publisher of Stem Cell Research News (1999), Stem Cell Business News (2002), and Stem Cell Lab World (2007), as well as the semi-annual Guide to Stem Cell Research Companies. DataTrends Equity Research Group, a unit of DataTrends Publications, provides independent research to small, growth-oriented public companies. DERG’s Investor’s Corporate Profile® is a comprehensive, detailed summary of a company’s business and growth strategies, history, financial data, leadership, science & technology, commercial products and products in the pipeline, markets, competition, patent portfolio and other intellectual property, strategic alliances, and risk factors.
Source DataTrends Publications, Inc.
http://www.DataTrendsPublications.com and http://www.StemCellResearchNews.com
###
Contact
DataTrends Publications, Inc.
Paul G. Ochs
571-313-9916
DataTrendsPublications.com
Paul G. Ochs
571-313-9916
DataTrendsPublications.com
Contact
Categories